B+
Bull case
20%
Probability
Target price
$19.50
Analysis reference price unavailable
Analysis 2026-01-30 · RankAlpha Sentiment AI
TAK
Takeda PharmaceuticalCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Bull case: Successful clinical readouts, clearer post-quarter guidance, and tangible cost-synergy realization drive re-rating toward the analyst high (19.5). Stronger-than-expected launch execution or an accretive licensing/M&A outcome would add incremental upside.
Posture
Mixed
Lead driver
Value
What changed
4 setup hits (3d) with net bullish as of 2026-10-24.
What can break
Failure to deliver integration synergies or cost savings
Momentum
90
Value
63
Sentiment
39
Setup hits (3d)
4 · Net Bullish
AI TargetsBase $17.00 · Bull $19.50 · Bear $14.87Analysis 2026-01-30; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-30 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Bullish
Target $20.76
Why
Momentum90 · Δ7d +5.4
Value63 · Δ7d -0.2
Sentiment39 · Δ7d -1.5
So what
Balanced signals (Net Bullish). Wait for confirmation before sizing up.
Confirming evidence
- • 4 setup hits (3d) with net bullish as of 2026-10-24.
- • Value remains the lead driver in the composite, 7D delta -0.2.
Contradictions & invalidation
- • Failure to deliver integration synergies or cost savings
- • Major litigation or product-safety event
- • Bear case: Negative readouts, guidance misses, or regulatory setbacks push the stock toward the analyst low (14.87).
Catalyst clock
2026-04-30
Next quarterly results (assumed window)
Lead driver: Value · See fundamentals
Momentum
90
8% active weight
Current posture
7d trendFlat
Δ7d
+5.4
Δ21d
+14.7
Value
63
47% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-1.2
Sentiment
39
45% active weight
Current posture
7d trendSoftening
Δ7d
-1.5
Δ21d
-20.3
Why this grade
Composite grade C. Momentum 90.4 / Value 62.6 / Sentiment 38.6
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-30. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-01-30 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$14.87
Analysis reference price unavailable
Analysis 2026-01-30 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$64.19B
Beta
0.05
Shares Out
3.18B
P/E (TTM)
226.9
P/S (TTM)
1.77
P/FCF (TTM)
12.72
Rev YoY
+0.0%
EPS YoY
-18.1%
Gross Margin
+54.5%
Op Margin
+15.3%
Net Debt
$30.68B
Current Ratio
1.14
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data